BioCad has announced that Dale Dental will be their exclusive outsource laboratory with rights to manufacture, design, and distribute BioCad products to laboratories within the U.S. BioCad offers ...

Russian biotech Biocad said it reached a deal with Sothema Labs of Morocco to produce biosimilars rituximab and bevacizumab, used to treat cancer. The St. Petersburg-based company said the drugs, ...

SAINT PETERSBURG, Russia--(BUSINESS WIRE)--The trastuzumab biosimilar, to be marketed under the trade name HERtiCAD™, is the first trastuzumab biosimilar to receive authorization from the Russian ...

Netakimab is a humanized anti-interleukin 17A antibody approved for the treatment of moderate-to-severe plaque psoriasis. Phase three clinical trial PATERA evaluated the effects of netakimab on signs ...

The biotechnology company BIOCAD has signed an agreement with the State Scientific Center for Virology and Biotechnology «Vektor» (Novosibirsk) on joint work on a vaccine based on rVSV against the ...

Roche has once again escaped a lawsuit claiming it went to illegal lengths to block biosimilars to its top-selling cancer meds. Russia’s Biocad sued Roche in 2016, claiming the Swiss drugmaker ...

A logo of BIOCAD company is seen on a door at the company's production facility in Saint Petersburg MOSCOW (Reuters) - Biotech group Biocad is discussing producing in China a potential COVID-19 ...

The biotechnology company BIOCAD has signed an agreement with the State Scientific Center for Virology and Biotechnology &laquoVektor» (Novosibirsk) on joint work on a vaccine based on rVSV against ...

Clinical trials of the vaccine are currently underway. The &laquoSputnik V» is the two-component vaccine. Revaccination is carried out at intervals of 3-4 weeks. Moreover, with the repeated ...

The manufacturing of Russian biosimilars of rituximab and bevacizumab indicated for the treatment of cancer, approved in the first half of October 2017, will be based in Morocco. “The efforts of our ...